Targeting XRCC1 Deficiency in Breast Cancer for Personalized TherapyRebeka Sultana, Srinivasan Madhusudan, Emad A. Rakha et al.|Cancer Research|2012Cited by 101
Clinicopathological and functional significance of XRCC1 expression in ovarian cancerTarek M.A. Abdel-Fatah, Srinivasan Madhusudan, Rebeka Sultana et al.|International Journal of Cancer|2012Cited by 64
Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapyTarek M. Abdel-Fatah, Srinivasan Madhusudan, Nada Albarakati et al.|Breast Cancer Research and Treatment|2013Cited by 35
Are DNA Repair Factors Promising Biomarkers for Personalized Therapy in Gastric Cancer?Tarek M.A. Abdel-Fatah, Srinivasan Madhusudan, Dileep N. Lobo et al.|Antioxidants and Redox Signaling|2012Cited by 24